A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial. (2017)

First Author: McAndrew A
Attributed to:  Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-017-1895-6

PubMed Identifier: 28372596

Publication URI: http://europepmc.org/abstract/MED/28372596

Type: Journal Article/Review

Volume: 18

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215